1. Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925-31.
2. 日本呼吸器学会 COPD ガイドライン第 5 版作成委員会. COPD(慢性閉塞性肺疾患)診断と治療のためのガイドライン第 5 版. 2018.
3. Burgel PR, Nesme-Meyer P, Chanez P, et al. Cough and sputum prouction are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest. 2009;135(4):975-82.
4. Kesimer M, Ford AA, Ceppe A, et al. Airway mucin concentration as a marker of chronic bronchitis. N Engl J Med. 2017;377(10):911-22.
5. Hiemstra PS, McCray PB Jr., Bals R. The innate immune function of airway epithelial cells in inflammatory lung disease. Eur Respir J. 2015;45(4):1150-62.
6. Parameswaran GI, Sethi S, Murphy TF. Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD. Chest. 2011;140(3):611-7.
7. Calverley PMA, Anzueto AR, Carter K, et al. Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial. Lancet Respir Med. 2018;6(5):337-44.
8. Naya I, Tombs L, Lipson DA, et al. Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis. Respir Res. 2019;20(1):60.
9. Wedzicha JA, Banerji D, Chapman KR, et al. Indacaterol-clycopyrronium versus salmeterol-fluticasone for COPD. N Engl J Med. 2016;374(23):2222-34.
10. Wedzicha JA, Decramer M, Ficker JH, et al. Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study. Lancet Respir Med.2013;1(3):199-209.
11. Beeh KM, Burgel PR, Franssen FME, et al. How do dual long-acting bronchodilators prevent exacerbations of hcronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2017;196(2):139-49.
12. Decramer ML, Chapman KR, Dahl R, et al. Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study. Lancet Respir Med.2013;1(7):524-33.
13. Vogelmeier C, Hederer B, Glaab T, et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med. 2011;364(12):1093-103.
14. Buhl R, Dunn LJ, Disdier C, et al. Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD. Eur Respir J. 2011;38(4):797-803.
15. Ichinose M, Taniguchi H, Takizawa A, et al. The efficacy and safety of combined tiotropium and olodaterol via the Respimat ® inhaler in patients with COPD: results from the Japanese sub-population of the Tonado® studies. Int J Chron Obstruct Pulmon Dis. 2016;11:2017-27.
16. Powrie DJ, Wilkinson TM, Donaldson GC, et al. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J. 2007;30(3):472-8.
17. Tagaya E, Yagi O, Sato A, et al. Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD. Pulm Pharmacol Ther. 2016;39:81-4.
18. Rossi A, Polese G. Indacaterol: a comprehensive review. Int J Chron Obstruct Pulmon Dis. 2013;8:353-63.
19. Anzalone G, Gagliardo R, Bucchieri F, et al. IL-17A induces chromatin remodeling promoting IL-8 release in bronchial epithelial cells: Effect of Tiotropium. Life Sci. 2016;152:107-16.
20. Barnes PJ. Distribution of receptor targets in the lung. Proc Am Thorac Soc. 2004;1(4):345-51.
21. Kistemaker LE, Gosens R. Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling. Trends Pharmacol Sci. 2015;36(3):164-71.
22. Pera T, Zuidhof A, Valadas J, et al. Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD. Eur Respir J. 2011;38(4):789-96.
23. Pilette C, Ouadrhiri Y, Godding V, et al. Lung mucosal immunity: immunoglobulin-A revisited. Eur Respir J. 2001;18(3):571-88.
24. Lee RJ, Foskett JK. Mechanisms of Ca2+-stimulated fluid secretion by porcine bronchial submucosal gland serous acinar cells. Am J Physiol Lung Cell Mol Physiol. 2010;298(2):L210-31.
25. Ousingsawat J, Martins JR, Schreiber R, et al. Loss of TMEM16A causes a defect in epithelial Ca2+-dependent chloride transport. J Biol Chem. 2009;284(42):28698-703.
26. Devor DC, Singh AK, Lambert LC, et al. Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells. Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells. J Gen Physiol. 1999;113(5):743-60.
27. Hug MJ, Tamada T, Bridges RJ. CFTR and bicarbonate secretion by [correction of to] epithelial cells. News in physiological sciences : News Physiol Sci. 2003;18:38-42.
28. Tamada T. TLRs and airway secretion. Respiration Research e Report. 2014;33(10):971-81.
29. Widdicombe JH. Ion and fluid transport by airway epithelium. New York. : Marcel Dekker Inc. ; 1994.
30. Widdicombe JH, Wine JJ. Airway Gland structure and function. Physiol Rev. 2015;95(4):1241-319.
31. Nadel JA, Davis B. Parasympathetic and sympathetic regulation of secretion from submucosal glands in airways. Fed Proc.1980;39(13):3075-9.
32. Bridges RJ. Mechanisms of bicarbonate secretion: lessons from the airways. Cold Spring Harb Perspect Med. 2012;2(8).
33. Tamada T, Hug MJ, Frizzell RA, et al. Microelectrode and impedance analysis of anion secretion in Calu-3 cells. JOP. 2001;2(4 Suppl):219-28.
34. Ballard ST, Inglis SK. Liquid secretion properties of airway submucosal glands. J Physiol. 2004;556(Pt 1):1-10.
35. Basbaum CB, Jany B, Finkbeiner WE. The serous cell. Annu Rev Physiol. 1990;52:97-113.
36. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363(23):2233-47.
37. Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest. 2002;109(5):571-7.
38. Widdicombe JH, Bastacky SJ, Wu DXY, et al. Regulation of depth and composition of airway surface liquid. J Anat. 1997;10(12):2892-7.
39. Buyck JM, Verriere V, Benmahdi R, et al. P. aeruginosa LPS stimulates calcium signaling and chloride secretion via CFTR in human bronchial epithelial cells. J Cyst Fibros. 2013;12(1):60-7.
40. Huang J, Kim D, Shan J, et al. Most bicarbonate secretion by Calu-3 cells is mediated by CFTR and independent of pendrin. Physiol Rep. 2018;6(5).
41. Muraglia KA, Chorghade RS, Kim BR, et al. Small-molecule ion channels increase host defences in cystic fibrosis airway epithelia. Nature. 2019;567(7748):405- 8.
42. Shah VS, Meyerholz DK, Tang XX, et al. Airway acidification initiates host defense abnormalities in cystic fibrosis mice. Science. 2016;351(6272):503-7.
43. Simonin J, Bille E, Crambert G, et al. Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis. Sci Rep. 2019;9(1):6516.
44. Coakley RD, Boucher RC. Regulation and functional significance of airway surface liquid pH. JOP 2001;2(4 Suppl):294-300.
45. Quinton PM. Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis. Lancet. 2008;372(9636):415-7.
46. Cowley EA, Linsdell P. Oxidant stress stimulates anion secretion from the human airway epithelial cell line Calu-3: implications for cystic fibrosis lung disease. J Physiol. 2002;543(Pt 1):201-9.
47. Baniak N, Luan X, Grunow A, et al. The cytokines interleukin-1beta and tumor necrosis factor-alpha stimulate CFTR-mediated fluid secretion by swine airway submucosal glands. Am J Physiol Lung Cell Mol Physiol. 2012;303(4):L327-33.
48. Boucher RC. Human airway ion transport. Part one. Am J Respir Crit Care Med. 1994;150(1):271-81.
49. Iwase N, Sasaki T, Shimura S, et al. Signature current of SO2-induced bronchitis in rabbit. J Clin Invest. 1997;99(7):1651-61.
50. Cantin AM, Hanrahan JW, Bilodeau G, et al. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med. 2006;173(10):1139-44.
51. Dransfield MT, Wilhelm AM, Flanagan B, et al. Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD. Chest. 2013;144(2):498-506.
52. Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1498-505.
53. Kong F, Young L, Chen Y, et al. Pseudomonas aeruginosa pyocyanin inactivates lung epithelial vacuolar ATPase-dependent cystic fibrosis transmembrane conductance regulator expression and localization. Cell Microbiol. 2006;8(7):1121-33.
54. MacEachran DP, Ye S, Bomberger JM, et al. The Pseudomonas aeruginosa secreted protein PA2934 decreases apical membrane expression of the cystic fibrosis transmembrane conductance regulator. Infect Immun. 2007;75(8):3902-12.
55. Schwarzer C, Fischer H, Kim EJ, et al. Oxidative stress caused by pyocyanin impairs CFTR Cl- transport in human bronchial epithelial cells. Free Radic Biol Med. 2008;45(12):1653-62.
56. Swiatecka-Urban A, Moreau-Marquis S, Maceachran DP, et al. Pseudomonas aeruginosa inhibits endocytic recycling of CFTR in polarized human airway epithelial cells. Am J Physiol Cell Physiol. 2006;290(3):C862-72.
57. Trinh NT, Bilodeau C, Maille E, et al. Deleterious impact of Pseudomonas aeruginosa on cystic fibrosis transmembrane conductance regulator function and rescue in airway epithelial cells. Eur Respir J. 2015;45(6):1590-602.
58. Hajighasemi-Ossareh M, Borthwell RM, Lachowicz-Scroggins M, et al. Distribution and size of mucous glands in the ferret tracheobronchial tree. Anat Rec (Hoboken). 2013;296(11):1768-74.
59. Widdicombe JH, Pecson IS. Distribution and numbers of mucous glands in the horse trachea. Equine Vet J. 2002;34(6):630-3.
60. Joo NS, Wu JV, Krouse ME, et al Optical method for quantifying rates of mucus secretion from single submucosal glands. Am J Physiol Lung Cell Mol Physiol. 2001;281(2):L458-68.
61. Iwase N, Sasaki T, Oshiro T, et al. Differential effect of epidermal growth factor on serous and mucous cells in porcine airway submucosal gland. Respir Physiol Neurobiol. 2002;132(3):307-19.
62. Murakami K, Tamada T, Nara M, et al. Toll-like receptor 4 potentiates Ca2+- dependent secretion of electrolytes from swine tracheal glands. Am J Respir Cell Mol Biol. 2011;45(5):1101-10.
63. Muramatsu S, Tamada T, Nara M, et al. Flagellin/TLR5 signaling potentiates airway serous secretion from swine tracheal submucosal glands. Am J Physiol Lung Cell Mol Physiol. 2013;305(11):L819-30.
64. Tamada T, Nara M, Kanatsuka H, et al. A potentiating effect of endogenous NO in the physiologic secretion from airway submucosal glands. Am J Respir Cell Mol Biol. 2007;37(3):357-65.
65. Tamada T, Sasaki T, Saitoh H, et al. A novel function of thyrotropin as a potentiator of electrolyte secretion from the tracheal gland. Am J Respir Cell Mol Biol. 2000;22(5):566-73.
66. Han J, Loudet A, Barhoumi R, et al. A ratiometric pH reporter for imaging protein-dye conjugates in living cells. J Am Chem Soc. 2009;131(5):1642-3.
67. Cazzola M, Calzetta L, Puxeddu E, et al. Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells. Respir Res. 2016;17(1):70.
68. Joo NS, Wine JJ, Cuthbert AW. Lubiprostone stimulates secretion from tracheal submucosal glands of sheep, pigs, and humans. Am J Physiol Lung Cell Mol Physiol. 2009;296(5):L811-24.
69. Joo NS, Cho HJ, Khansaheb M, et al. Hyposecretion of fluid from tracheal submucosal glands of CFTR-deficient pigs. J Clin Invest. 2010;120(9):3161-6.
70. Sun X, Sui H, Fisher JT, et al. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest. 2010;120(9):3149-60.
71. Kreft ME, Jerman UD, Lasic E, et al. The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function. European journal of pharmaceutical sciences : Eur J Pharm Sci. 2015;69:1-9.
72. Gamo S, Tamada T, Murakami K, et al. TLR7 agonist attenuates acetylcholine- induced, Ca2+ -dependent ionic currents in swine tracheal submucosal gland cells. Exp Physiol. 2018;103(11):1543-59.
73. Ameen N, Silvis M, Bradbury NA. Endocytic trafficking of CFTR in health and disease. J Cyst Fibros. 2007;6(1):1-14.
74. Farinha CM, Matos P, Amaral MD. Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the Golgi. FEBS J . 2013;280(18):4396-406.
75. Saint-Criq V, Villeret B, Bastaert F, et al. Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator-IL-6-antimicrobial-repair pathway. Thorax. 2018;73(1):49-61.
76. Marklew AJ, Patel W, Moore PJ, et al. Cigarette smoke exposure induces retrograde trafficking of CFTR to the endoplasmic reticulum. Sci Rep. 2019;9(1):13655.
77. Sloane PA, Shastry S, Wilhelm A, et al. A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease. PLoS One. 2012;7(6):e39809.